-
2
-
-
51349094780
-
AAN-EFNS guidelines on trigeminal neuralgia management
-
18721143 10.1111/j.1468-1331.2008.02185.x 1:STN:280: DC%2BD1cnivFCrtA%3D%3D
-
Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2008;15(10):1013-28.
-
(2008)
Eur J Neurol
, vol.15
, Issue.10
, pp. 1013-1028
-
-
Cruccu, G.1
Gronseth, G.2
Alksne, J.3
-
3
-
-
55249119499
-
Practice parameter: The diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies
-
18716236 10.1212/01.wnl.0000326598.83183.04 1:STN:280: DC%2BD1cnksVyitQ%3D%3D
-
Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology. 2008;71(15):1183-90.
-
(2008)
Neurology
, vol.71
, Issue.15
, pp. 1183-1190
-
-
Gronseth, G.1
Cruccu, G.2
Alksne, J.3
-
4
-
-
66749092091
-
Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: Evidence from medical practice in primary care settings
-
19522052 10.1111/j.1468-2982.2008.01792.x
-
Pérez C, Navarro A, Saldaña MT, et al. Patient-reported outcomes in subjects with painful trigeminal neuralgia receiving pregabalin: evidence from medical practice in primary care settings. Cephalalgia. 2009;29(7):781-90.
-
(2009)
Cephalalgia
, vol.29
, Issue.7
, pp. 781-790
-
-
Pérez, C.1
Navarro, A.2
Saldaña, M.T.3
-
5
-
-
65449138272
-
Trigeminal neuralgia treated with pregabalin in family medicine settings: Its effect on pain alleviation and cost reduction
-
19299534 10.1177/0091270009333017
-
Pérez C, Saldaña MT, Navarro A, et al. Trigeminal neuralgia treated with pregabalin in family medicine settings: its effect on pain alleviation and cost reduction. J Clin Pharmacol. 2009;49(5):582-90.
-
(2009)
J Clin Pharmacol
, vol.49
, Issue.5
, pp. 582-590
-
-
Pérez, C.1
Saldaña, M.T.2
Navarro, A.3
-
6
-
-
77954446485
-
A fMRI evaluation of lamotrigine for the treatment of trigeminal neuropathic pain: Pilot study
-
20492571 10.1111/j.1526-4637.2010.00859.x
-
Scrivani S, Wallin D, Moulton EA, et al. A fMRI evaluation of lamotrigine for the treatment of trigeminal neuropathic pain: pilot study. Pain Med. 2010;11(6):920-41.
-
(2010)
Pain Med
, vol.11
, Issue.6
, pp. 920-941
-
-
Scrivani, S.1
Wallin, D.2
Moulton, E.A.3
-
7
-
-
67650679279
-
World institute of medicine: 1. Trigeminal neuralgia
-
10.1111/j.1533-2500.2009.00298.x
-
van Kleef M, van Genderen WE, Narouze S, et al. World institute of medicine: 1. Trigeminal neuralgia. Pain Pract. 2009;4:252-9.
-
(2009)
Pain Pract
, vol.4
, pp. 252-259
-
-
Van Kleef, M.1
Van Genderen, W.E.2
Narouze, S.3
-
8
-
-
58149157911
-
Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
-
19004549 10.1016/j.pain.2008.10.005 1:CAS:528:DC%2BD1MXjvFSqtA%3D%3D
-
Gazerani P, Pedersen NS, Staahl C, et al. Subcutaneous botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin. Pain. 2009;141(1-2):60-9.
-
(2009)
Pain
, vol.141
, Issue.1-2
, pp. 60-69
-
-
Gazerani, P.1
Pedersen, N.S.2
Staahl, C.3
-
9
-
-
41549084998
-
Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia
-
18378142 10.1016/j.jocn.2007.04.010 1:CAS:528:DC%2BD1cXktlCktbk%3D
-
Gomez-Arguelles JM, Dorado R, Sepulveda JM, et al. Oxcarbazepine monotherapy in carbamazepine-unresponsive trigeminal neuralgia. J Clin Neurosci. 2008;15(5):516-9.
-
(2008)
J Clin Neurosci
, vol.15
, Issue.5
, pp. 516-519
-
-
Gomez-Arguelles, J.M.1
Dorado, R.2
Sepulveda, J.M.3
-
10
-
-
34548861506
-
Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain
-
17662571 10.1016/j.jpainsymman.2006.12.015 1:CAS:528:DC%2BD2sXht1GksrnJ
-
Silver M, Blum D, Grainger J, et al. Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain. J Pain Symptom Manage. 2007;34(4):446-54.
-
(2007)
J Pain Symptom Manage
, vol.34
, Issue.4
, pp. 446-454
-
-
Silver, M.1
Blum, D.2
Grainger, J.3
-
11
-
-
79957502800
-
Lamotrigine for trigeminal neuralgia: Efficacy and safety in comparison with carbamazepine
-
21621166 10.1016/j.jcma.2011.04.002 1:CAS:528:DC%2BC3MXmvFCqtbs%3D
-
Shaikh S, Yaacob HB, Abd Rahman RB. Lamotrigine for trigeminal neuralgia: efficacy and safety in comparison with carbamazepine. J Chin Med Assoc. 2011;74(6):243-9.
-
(2011)
J Chin Med Assoc
, vol.74
, Issue.6
, pp. 243-249
-
-
Shaikh, S.1
Yaacob, H.B.2
Abd Rahman, R.B.3
-
12
-
-
0030810189
-
Lamotrigine (lamictal) in refractory trigeminal neuralgia: Results from a double-blind placebo controlled crossover trial
-
9415509 10.1016/S0304-3959(97)00104-8 1:CAS:528:DyaK2sXnt1eqsL0%3D
-
Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 1997;73(2):223-30.
-
(1997)
Pain
, vol.73
, Issue.2
, pp. 223-230
-
-
Zakrzewska, J.M.1
Chaudhry, Z.2
Nurmikko, T.J.3
-
14
-
-
20044376310
-
Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4)
-
15733628 10.1016/j.pain.2004.12.010
-
Bouhassira D, Attal N, Alchaar H, et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain. 2005;114(1-2):29-36.
-
(2005)
Pain
, vol.114
, Issue.1-2
, pp. 29-36
-
-
Bouhassira, D.1
Attal, N.2
Alchaar, H.3
-
15
-
-
65449130768
-
Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia
-
19475723 10.1111/j.1468-1331.2009.02585.x 1:STN:280: DC%2BD1MznsFeitg%3D%3D
-
Jorns TP, Johnston A, Zakrzewska JM. Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. Eur J Neurol. 2009;16(6):740-4.
-
(2009)
Eur J Neurol
, vol.16
, Issue.6
, pp. 740-744
-
-
Jorns, T.P.1
Johnston, A.2
Zakrzewska, J.M.3
-
16
-
-
33748870381
-
Intranasal lidocaine 8% spray for second-division trigeminal neuralgia
-
16882684 10.1093/bja/ael180 1:CAS:528:DC%2BD28Xps1ygtLs%3D
-
Kanai A, Suzuki A, Kobayashi M, et al. Intranasal lidocaine 8% spray for second-division trigeminal neuralgia. Br J Anaesth. 2006;97(4):559-63.
-
(2006)
Br J Anaesth
, vol.97
, Issue.4
, pp. 559-563
-
-
Kanai, A.1
Suzuki, A.2
Kobayashi, M.3
-
17
-
-
33645453357
-
Subcutaneous sumatriptan for refractory trigeminal neuralgia
-
16643550 10.1111/j.1526-4610.2006.00405.x (discussion 583-4)
-
Kanai A, Saito M, Hoka S. Subcutaneous sumatriptan for refractory trigeminal neuralgia. Headache. 2006;46(4):577-82. (discussion 583-4).
-
(2006)
Headache
, vol.46
, Issue.4
, pp. 577-582
-
-
Kanai, A.1
Saito, M.2
Hoka, S.3
-
18
-
-
33748937219
-
Sumatriptan alleviates pain in patients with trigeminal neuralgia
-
16988562 10.1097/01.ajp.0000210917.18536.0d
-
Kanai A, Suzuki A, Osawa S, et al. Sumatriptan alleviates pain in patients with trigeminal neuralgia. Clin J Pain. 2006;22(8):677-80.
-
(2006)
Clin J Pain
, vol.22
, Issue.8
, pp. 677-680
-
-
Kanai, A.1
Suzuki, A.2
Osawa, S.3
-
19
-
-
38049020721
-
Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone
-
18180639 10.1097/AJP.0b013e318158011a
-
Lemos L, Flores S, Oliveira P, et al. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain. 2008;24(1):64-75.
-
(2008)
Clin J Pain
, vol.24
, Issue.1
, pp. 64-75
-
-
Lemos, L.1
Flores, S.2
Oliveira, P.3
-
20
-
-
84856102576
-
Treatment of trigeminal neuralgia with bupivacaine HCL using a temporary epidural catheter and pain pump: Preliminary study
-
21546257 10.1016/j.jcms.2011.03.022
-
Dergin G, Gocmen G, Sener BC. Treatment of trigeminal neuralgia with bupivacaine HCL using a temporary epidural catheter and pain pump: preliminary study. J Craniomaxillofac Surg. 2012;40(2):124-8.
-
(2012)
J Craniomaxillofac Surg
, vol.40
, Issue.2
, pp. 124-128
-
-
Dergin, G.1
Gocmen, G.2
Sener, B.C.3
-
21
-
-
38149117161
-
Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia
-
18036166 10.1111/j.1742-1241.2007.01568.x 1:CAS:528:DC%2BC3cXktFGgtLk%3D
-
Han KR, Kim C, Chae YJ, et al. Efficacy and safety of high concentration lidocaine for trigeminal nerve block in patients with trigeminal neuralgia. Int J Clin Pract. 2008;62(2):248-54.
-
(2008)
Int J Clin Pract
, vol.62
, Issue.2
, pp. 248-254
-
-
Han, K.R.1
Kim, C.2
Chae, Y.J.3
-
22
-
-
78650418411
-
Use of botulinum toxin A for drug-refractory trigeminal neuralgia: Preliminary report
-
20674409 10.1016/j.tripleo.2010.04.043
-
Bohluli B, Motamedi MH, Bagheri SC, et al. Use of botulinum toxin A for drug-refractory trigeminal neuralgia: preliminary report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;111(1):47-50.
-
(2011)
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
, vol.111
, Issue.1
, pp. 47-50
-
-
Bohluli, B.1
Motamedi, M.H.2
Bagheri, S.C.3
-
23
-
-
84861800887
-
Botulinum toxin type A for the treatment of trigeminal neuralgia: Results from a randomized, double-blind, placebo-controlled trial
-
22492424 10.1177/0333102412441721
-
Wu CJ, Lian YJ, Zheng YK, et al. Botulinum toxin type A for the treatment of trigeminal neuralgia: results from a randomized, double-blind, placebo-controlled trial. Cephalalgia. 2012;32(6):443-50.
-
(2012)
Cephalalgia
, vol.32
, Issue.6
, pp. 443-450
-
-
Wu, C.J.1
Lian, Y.J.2
Zheng, Y.K.3
-
24
-
-
64149128169
-
Comment on AAN-EFNS guidelines on trigeminal neuralgia management
-
19405206 10.1111/j.1468-1331.2009.02584.x 1:STN:280: DC%2BD1MzhtFSmtw%3D%3D
-
Teive HA, Piovesan EJ, Kowacs PA, et al. Comment on AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol. 2009;16(5):e105.
-
(2009)
Eur J Neurol
, vol.16
, Issue.5
, pp. 105
-
-
Teive, H.A.1
Piovesan, E.J.2
Kowacs, P.A.3
-
25
-
-
52949097981
-
Beneficial effects of botulinum toxin type A in trigeminal neuralgia
-
18813708 10.1590/S0004-282X2008000400012
-
Zúñiga C, Díaz S, Piedimonte F, et al. Beneficial effects of botulinum toxin type A in trigeminal neuralgia. Arq Neuropsiquiatr. 2008;66(3A):500-3.
-
(2008)
Arq Neuropsiquiatr
, vol.66
, Issue.3 A
, pp. 500-503
-
-
Zúñiga, C.1
Díaz, S.2
Piedimonte, F.3
-
26
-
-
27144451747
-
An open study of botulinum-A toxin treatment of trigeminal neuralgia
-
16247065 10.1212/01.wnl.0000180940.98815.74 1:CAS:528:DC%2BD2MXhtV2jsbjO
-
Piovesan EJ, Teive HG, Kowacs PA, et al. An open study of botulinum-A toxin treatment of trigeminal neuralgia. Neurology. 2005;65(8):1306-8.
-
(2005)
Neurology
, vol.65
, Issue.8
, pp. 1306-1308
-
-
Piovesan, E.J.1
Teive, H.G.2
Kowacs, P.A.3
-
27
-
-
23644431890
-
Botulinum toxin and intractable trigeminal neuralgia
-
16062093 10.1097/01.wnf.0000172497.24770.b0
-
Türk U, Ilhan S, Alp R, et al. Botulinum toxin and intractable trigeminal neuralgia. Clin Neuropharmacol. 2005;28(4):161-2.
-
(2005)
Clin Neuropharmacol
, vol.28
, Issue.4
, pp. 161-162
-
-
Türk, U.1
Ilhan, S.2
Alp, R.3
-
28
-
-
0036175202
-
The use of botulinum toxin for the treatment of chronic facial pain
-
14622850 10.1054/jpai.2002.27142
-
Borodic GE, Acquadro MA. The use of botulinum toxin for the treatment of chronic facial pain. J Pain. 2002;3(1):21-7.
-
(2002)
J Pain
, vol.3
, Issue.1
, pp. 21-27
-
-
Borodic, G.E.1
Acquadro, M.A.2
-
29
-
-
26444469528
-
Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A
-
16002144 10.1016/j.neuro.2005.01.017 1:CAS:528:DC%2BD2MXhtFWhsLnJ
-
Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785-93.
-
(2005)
Neurotoxicology
, vol.26
, Issue.5
, pp. 785-793
-
-
Aoki, K.R.1
-
30
-
-
80054102660
-
Updates on the antinociceptive mechanism hypothesis of botulinum toxin A
-
21999893 10.1016/j.parkreldis.2011.06.013
-
Aoki KR, Francis J. Updates on the antinociceptive mechanism hypothesis of botulinum toxin A. Parkinsonism Relat Disord. 2011;17(Suppl. 1):S28-33.
-
(2011)
Parkinsonism Relat Disord
, vol.17
, Issue.SUPPL. 1
-
-
Aoki, K.R.1
Francis, J.2
-
31
-
-
11444254396
-
The mechanism of the pain in trigeminal neuralgia
-
13642075 10.1136/jnnp.22.1.36 1:STN:280:DyaG1M%2FntFKrsg%3D%3D
-
Kugelberg E, Lindblom U. The mechanism of the pain in trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 1959;22(1):36-43.
-
(1959)
J Neurol Neurosurg Psychiatry
, vol.22
, Issue.1
, pp. 36-43
-
-
Kugelberg, E.1
Lindblom, U.2
-
33
-
-
65449178130
-
Trigeminal neuralgia and pain related to multiple sclerosis
-
19171430 10.1016/j.pain.2008.12.026 1:STN:280:DC%2BD1MzjvVKhtQ%3D%3D
-
Cruccu G, Biasiotta A, Di Rezze S, et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain. 2009;143(3):186-91.
-
(2009)
Pain
, vol.143
, Issue.3
, pp. 186-191
-
-
Cruccu, G.1
Biasiotta, A.2
Di Rezze, S.3
|